The University of Michigan School of Dentistry is the dental school of the University of Michigan, located in Ann Arbor, Michigan. Established in 1875, the School of Dentistry engages in oral and craniofacial health care education, research, patient care and community service.

During the past decade, University of Michigan School of Dentistry conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 11 clinical trials were completed, i.e. on average, 30.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Michigan School of Dentistry" #1 sponsor was "University of Michigan" with 33 trials, followed by "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 3 trials sponsored, "3M" with 1 trials sponsored, "Geistlich Pharma AG" with 1 trials sponsored and "Heba Mitwalli" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Michigan School of Dentistry" #1 collaborator was "Delta Dental Foundation" with 3 trials as a collaborator, "National Institute of Dental and Craniofacial Research (NIDCR)" with 3 trials as a collaborator, "Delta Dental Fund of Michigan" with 2 trials as a collaborator, "Dentsply Sirona Implants and Consumables" with 2 trials as a collaborator and "Morita J USA" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Michigan School of Dentistry" are "Peri-Implantitis" (4 trials), "Caries" (3 trials), "Dental Caries" (3 trials), "Gingival Recession" (3 trials) and "Pulmonary Arterial Hypertension" (3 trials). Many other conditions were trialed in "University of Michigan School of Dentistry" in a lesser frequency.

Most popular intervention types in "University of Michigan School of Dentistry" are "Device" (17 trials), "Drug" (8 trials), "Other" (8 trials), "Procedure" (7 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Observation" (3 trials), "Sotatercept" (3 trials), "Silver Diamine Fluoride" (2 trials) and "Active Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Michigan School of Dentistry" are 42 trials for "All" genders.

Currently, there are 13 active trials in "University of Michigan School of Dentistry". 1 are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 22 completed trials in University of Michigan School of Dentistry, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Michigan School of Dentistry, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 21 trials that are defined as “Not Applicable".